| 发明名称 |
Use of erythropoietin for treating diabetes mellitus |
| 摘要 |
Disclosed is the use of erythropoietin for producing a pharmaceutical composition comprising a subpolycythemic EPO-dosis corresponding to a weekly dosis of 1 to 90 international units (IU) EPO/kg body weight for the therapy of diabetes mellitus.
|
| 申请公布号 |
NZ553426(A) |
申请公布日期 |
2008.07.31 |
| 申请号 |
NZ20030553426 |
申请日期 |
2003.07.25 |
| 申请人 |
EPOPLUS GMBH & CO. KG |
发明人 |
BAHLMANN, FERDINAND HERMANN;HALLER, HERMANN |
| 分类号 |
(IPC1-7):A61K38/18;A61K38/19;A61L27/38;A61P9/00 |
主分类号 |
(IPC1-7):A61K38/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
